COCH
Envoy Medical Inc - Ordinary Shares - Class A

747
Mkt Cap
$59.69M
Volume
1.75M
52W High
$1.91
52W Low
$0.3625
PE Ratio
-0.58
COCH Fundamentals
Price
$0.7764
Prev Close
$0.8267
Open
$0.8263
50D MA
$0.6808
Beta
0.36
Avg. Volume
1.85M
EPS (Annual)
-$1.49
P/B
-2.41
Rev/Employee
$5,357.14
$41.05
Loading...
Loading...
News
all
press releases
EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear
Envoy Medical completes enrollment for its Acclaim cochlear implant trial, a fully implanted device designed without external components.read more...
Benzinga·10d ago
News Placeholder
More News
News Placeholder
Insider Buying: Envoy Medical (NASDAQ:COCH) Major Shareholder Buys 18,750,000 Shares of Stock
Envoy Medical, Inc. (NASDAQ:COCH - Get Free Report) major shareholder Glen Taylor purchased 18,750,000 shares of the business's stock in a transaction that occurred on Thursday, February 12th. The...
MarketBeat·1mo ago
News Placeholder
Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why
Envoy Medical, Inc. (COCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·4mo ago
News Placeholder
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -29.63% and -23.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -10.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?
Envoy Medical, Inc. (COCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·5mo ago
News Placeholder
Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of +37.50% and +6.88%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates
Delcath Systems (DCTH) delivered earnings and revenue surprises of 0.00% and +0.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +7.69% and -2.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' Now
Envoy Medical, Inc. (COCH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Zacks·5mo ago
<
1
2
...
>

Latest COCH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.